Partnering, Licensing and Investment Opportunities
UHN has products and technologies available for commercialization in the following areas:
Life Sciences: Research reagents such as cell lines and antibodies; biomarkers and diagnostics; drug delivery and screening platforms; and innovative small molecules, biologics, and cell-based therapeutics
Med-tech, Devices and Software: Technologies related to regenerative medicine; to stroke and spinal cord injury rehabilitation; and to radiation oncology, imaging, image-guided interventions; AI-based tools and mobile apps
Clinical Tools and Questionnaires: Quality and regulatory tools and tools to measure outcomes
For additional information regarding UHN’s products and technologies, please contact our office. Our Licensing and Commercialization Professionals can answer questions and guide you to the right technologies and scientific resources to meet your organization’s needs.
Search our database of current partnership, licensing and investment opportunities: